The best timing for administering systemic chemotherapy in patients with locally advanced rectal cancer

about

The best timing for administering systemic chemotherapy in patients with locally advanced rectal cancer

Item

http://www.wikidata.org/entity/Q36516445

description

2016 nî lūn-bûn

@nan

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

name

The best timing for administer ...... locally advanced rectal cancer

@ast

The best timing for administer ...... locally advanced rectal cancer

@en

type

Item

label

The best timing for administer ...... locally advanced rectal cancer

@ast

The best timing for administer ...... locally advanced rectal cancer

@en

prefLabel

The best timing for administer ...... locally advanced rectal cancer

@ast

The best timing for administer ...... locally advanced rectal cancer

@en

P1476

The best timing for administer ...... locally advanced rectal cancer

@en

P2093

Kazuto Harada

http://www.w3.org/2001/XMLSchema#string

Quan Lin

http://www.w3.org/2001/XMLSchema#string

Yusuke Shimodaira

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2015

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study

Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data.

Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07.

Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer.

Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3978/J.ISSN.2305-5839.2016.01.08

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jaffer Ajani

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26889491

http://www.w3.org/2001/XMLSchema#string

P932

4731594

http://www.w3.org/2001/XMLSchema#string